共 50 条
- [42] Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States JOURNAL OF BLOOD MEDICINE, 2022, 13 : 517 - 524
- [43] Comment on "Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies" SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2022, 48 (02): : 251 - 252